𝐀𝐝𝐚𝐦𝐞𝐭𝐍𝐞𝐱𝐭 𝐚𝐭 ESMO - European Society for Medical Oncology, 𝐁𝐚𝐫𝐜𝐞𝐥𝐨𝐧𝐚! Our team—Virendra Kumar, Ziya Pailwan, and Dr. Kumud Joshi—will attend ESMO in Barcelona from September 13th to 17th. We'd like to discuss your business needs! Send us a direct message or email us at [email protected].
AdametNext
Business Consulting and Services
Duluth, Georgia 10,932 followers
Integrating Competitive Insights into Global Brand Strategy for Pharma/Healthcare Business Owners
About us
We are a team of highly specialized pharma professionals who understand the science and business priorities of a pharmaceutical brand management team. We help business owners in making data-driven decision-making by providing timely information and proactive insights. For regular updates, follow us on Instagram - https://www.instagram.com/adametnext/ Facebook - https://www.facebook.com/adametnext Twitter - https://twitter.com/adametnext We understand that business insights are not built-in silos and often require cross-team inputs—for example, commercial, medical, patient advocacy, market access, etc. So our experienced professionals monitor a brand 360 to provide actionable insights to business owners. Please write us at [email protected] or visit our website www.adametnext.com for more information.
- Website
-
http://www.adametnext.com
External link for AdametNext
- Industry
- Business Consulting and Services
- Company size
- 51-200 employees
- Headquarters
- Duluth, Georgia
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Situation Analysis, Competitive Intelligence, Competitive Readiness, Conference Coverage, Primary Research, Secondary Research, Pipeline Analysis, Competition Benchmarking, Commercial Analysis, Clinical Product Differentiation, KOL Perception Analysis, and Social Media Monitoring
Locations
-
Primary
Get directions
1840 Noblin Ridge Way
Duluth, Georgia 30097, US
-
Get directions
ISB Road
AWFIS, 5th Floor Raja Pushpa Summit
ISB Road, Telangana 500032, IN
Employees at AdametNext
-
Hemant Kumar
Executive Director at Adamet Motors Pvt Ltd & Director at Adametnext LLP
-
Yamini Kaushal
-
Pramod Sathe
Business Consultant and Founder of Georgia Consulting LLC
-
Virendra Kumar
Managing Director | Offshore Integrated Pharma Brand Insights - CI, FC, BA & MR | Ex-Novartis | Ex-GSK | Ex-Bayer
Updates
-
We are excited to welcome Himanshukumar Patel, Arpita Panigrahi, and Sushant Kadam to the AdametNext team! They bring fresh perspectives and a passion for innovation. Their enthusiasm is sure to inspire and drive our projects forward. Welcome aboard! – let's achieve great things together! AdametNext #NewHire #TeamAdametNext #Innovation
-
-
Explore 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚 𝐂𝐈/𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐉𝐨𝐛 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐟𝐨𝐫 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟒, featuring career openings with industry leaders like Amgen, AbbVie, Gilead Sciences, and more. 𝐊𝐞𝐲 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐑𝐨𝐥𝐞𝐬: CDnA - Commercial Analytics Manager, Inflammation – Thousand Oaks, CA (Hybrid) | Amgen Associate Director, Competitive Intelligence – Boston, MA (Hybrid) | AbbVie Executive Director, US Integrated Insights – Foster City, CA | Gilead Sciences Director of Customer Engagement - Insights and Analytics – Remote | Bayer & more 𝐀𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝐕𝐚𝐫𝐢𝐨𝐮𝐬 𝐋𝐨𝐜𝐚𝐭𝐢𝐨𝐧𝐬: ⚡ Novartis India in Hyderabad, India ⚡ AbbVie in Boston, MA and Irvine, CA ⚡ Gilead Sciences in Foster City, CA ⚡ UCB in Atlanta, GA Don’t miss these outstanding opportunities to advance your career in Global Pharma CI/Insights. Stay connected and follow us for monthly job updates! AdametNext
-
AdametNext reposted this
Our Independence Day celebration at AdametNext was a vibrant tapestry of patriotism, painted in the hues of our flag. Decked out in tricolor, we engaged in a captivating quiz that challenged and entertained! It was a day of joyous camaraderie and a profound sense of Indian pride. In our pursuit of excellence, we remain dedicated to embodying the finest qualities of our Indian heritage. Jai Hind! Let's continue to channel this fervor into our endeavors, as we unite to innovate and excel. Together, we are the heartbeat of AdametNext. Happy Independence Day! #AdametNext #Pride #Innovation #Unity #JaiHind
-
-
Our Independence Day celebration at AdametNext was a vibrant tapestry of patriotism, painted in the hues of our flag. Decked out in tricolor, we engaged in a captivating quiz that challenged and entertained! It was a day of joyous camaraderie and a profound sense of Indian pride. In our pursuit of excellence, we remain dedicated to embodying the finest qualities of our Indian heritage. Jai Hind! Let's continue to channel this fervor into our endeavors, as we unite to innovate and excel. Together, we are the heartbeat of AdametNext. Happy Independence Day! #AdametNext #Pride #Innovation #Unity #JaiHind
-
-
𝐌𝐞𝐞𝐭 𝐔𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐏𝐡𝐚𝐫𝐦𝐚 𝐂𝐈 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 & 𝐄𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧! At AdametNext, we specialize in Integrated Product Strategy to stay ahead in today’s dynamic pharmaceutical landscape. Learn about our 𝐏𝐡𝐚𝐫𝐦𝐚 𝐂𝐈 with 𝐈𝐧𝐬𝐢𝐝𝐞-𝐎𝐮𝐭 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲 from our industry experts - Virendra Kumar and Amit Pharande ,who will provide strategic insights to navigate challenges and seize opportunities in pharma. Our 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞𝐝 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 global, regional, and country brand teams, as well as global program teams, by addressing gaps in product positioning, target profiles, and brand identity. Additionally offering detailed situation analysis for brands and portfolios. 📅 Save the Date: September 25th & 26th, 2024 📍 Newark, NJ Don’t miss out on this exclusive opportunity to connect with us at Pharma CI and explore how our expertise can drive your business forward. #CompetitiveReadiness #MarketIntelligence #PharmaCI #Newark #AdametNext
-
-
𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐦𝐚𝐫𝐤𝐞𝐭: 𝐕𝐚𝐬𝐨𝐦𝐨𝐭𝐨𝐫 𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬 𝐃𝐮𝐞 𝐭𝐨 𝐌𝐞𝐧𝐨𝐩𝐚𝐮𝐬𝐞 Menopause can bring a range of vasomotor symptoms (VMS) like hot flashes and night sweats, impacting women's daily lives and well-being. We recognize the importance of addressing these symptoms and improving quality of life. VMS affects millions, leading to discomfort, sleep disturbances, and emotional challenges. 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞: 𝐇𝐨𝐫𝐦𝐨𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲, 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐎𝐩𝐭𝐢𝐨𝐧𝐬, 𝐒𝐒𝐑𝐈𝐬 Exciting advancements in non-hormonal therapies are on the horizon, offering new hope for those affected by VMS. For feedback and further query, please connect with Amit Pharande, Chandan Mallick, Shilpa Lalwani (Tahilramani), Firasat Ali Syed and Sharik Saifi ✍ Write to us at [email protected] for more exciting updates! AdametNext Join us in spreading awareness and supporting women's health! 🌟 #MenopauseAwareness #WomensHealth #VMS #InnovativeTreatments #Healthcare
-
AdametNext reposted this
You can learn more about our medical conference coverage solutions.
Managing Director | Offshore Integrated Pharma Brand Insights - CI, FC, BA & MR | Ex-Novartis | Ex-GSK | Ex-Bayer
At AdametNext, we see the medical conferences (Trade Shows) from the global commercial or medical director's point of view. The presentation I've attached is only prepared for the critical decision-makers who understand the value of timely insights for strategic decision-making. Our coverage provides the strategic direction of the industry and individual competitors. We also follow the mantra of 'Start with Why' philosophy by Simon Sinek. Why - Purpose How - Process What - Outcome Please contact me to learn more about our unique approach to conference coverage solutions. We can also meet at the upcoming #PharmaCI2023 conference in New Jersey, US.
-
AdametNext reposted this
Pharma/Biotech Consulting | Competitive Intelligence | Data Insights | Strategy | Oncology | Genomics | Personalized Medicine
𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐈𝐠𝐀 𝐍𝐞𝐩𝐡𝐫𝐨𝐩𝐚𝐭𝐡𝐲 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐍𝐞𝐞𝐝 𝐟𝐨𝐫 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 IgA nephropathy (IgAN), also known as Berger's disease, is a rare kidney disorder characterized by the deposition of immunoglobulin A (IgA) antibodies in the glomeruli. This leads to kidney inflammation and may eventually result in end-stage renal disease (ESRD) or kidney failure. The current standard of care includes the use of renin-angiotensin-aldosterone system (RAAS) blockers and adequate blood pressure control. However, the risk of kidney failure remains high. There is a pressing need for effective, targeted therapies for IgAN that can help slow or prevent progression to kidney failure. Multiple ongoing phase 3 trials offer hope for improved clinical management of the disease in the future. Active companies in the IgAN space: Arrowhead Pharmaceuticals, Takeda, Alexion Pharmaceuticals, Inc., Apellis Pharmaceuticals, Biogen, Novartis, RemeGen Biosciences, Vera Therapeutics, Inc., Roche, Otsuka Pharmaceutical Co., Ltd., Travere Therapeutics, Calliditas Therapeutics For feedback and further query, please connect with Nishu Sharma, Dr. Ankit Srivastava, PhD, and Simrat Kaur ✍ Write to us at [email protected] for more exciting updates! AdametNext #IgAN #IgANephropathy #kidneydisease #nephrology #strategy #marketintelligence #competitiveintelligence
-
AdametNext reposted this
Our in-dept analysis at 𝟐𝐧𝐝 𝐉𝐏 𝐌𝐨𝐫𝐠𝐚𝐧 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 brings you actionable insights on 𝟔𝟖+ 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬. Want to know what's shaping the future of healthcare? 𝐅𝐨𝐫 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐲-𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐰𝐫𝐢𝐭𝐞 𝐮𝐬 𝐚𝐭 [email protected] #healthcareinsights #jpmorganhealthcare #industrytrends #JPMorgan #AdametNext
-